Jeff Albers, JD

Jeff Albers is an accomplished leader with over 25 years in the biopharmaceutical industry. As the former CEO of Blueprint Medicines, he scaled the company from a research-stage organization to a global precision medicine leader. Jeff was responsible for two US Food and Drug Administration (FDA) approvals. Jeff currently is board chair of Blueprint Medicines, and sits on the board of directors at Kymera Therapeutics and Spyre Therapeutics. He earned a BS from Indiana University as well as an MBA and JD from Georgetown University.